Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
[F2][F1]2026-01-08+30,000→ 30,000 totalExercise: $18.83Exp: 2036-01-08→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The option was granted on January 8, 2026. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 8, 2027.
- [F2]Not applicable.
Signature
/s/ Bhaskar Anand|2026-01-12